Exousia Bio (LMMY) Non-Current Assets (2022 - 2025)

Exousia Bio has disclosed Non-Current Assets across 4 years of filings, most recently posting $22.1 million for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $22.1 million, up 308862.73% year-over-year; the trailing twelve-month figure through Nov 2025 was $22.1 million (up 308862.73% YoY), and the FY2024 annual result was $14489.0, down 50.36% from the prior year.
• Non-Current Assets came in at $22.1 million for Q4 2025 at Exousia Bio, up from $7137.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $22.1 million in Q4 2025 to a low of $7137.0 in Q4 2024.
• The 4-year median for Non-Current Assets is $23676.5 (2023), against an average of $2.2 million.
• Across the five-year window, Non-Current Assets slumped 67.32% in 2024 and jumped 308862.73% in 2025, its largest moves.
• Exousia Bio's Non-Current Assets stood at $43889.0 in 2022, then sank by 50.24% to $21839.0 in 2023, then plunged by 67.32% to $7137.0 in 2024, then surged by 308862.73% to $22.1 million in 2025.
• The last three Non-Current Assets figures came in at $22.1 million (Q4 2025), $7137.0 (Q4 2024), and $10813.0 (Q3 2024), per Business Quant data.